Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
Retinitis pigmentosa (RP) is a heterogeneous group of hereditary diseases characterized by progressive degeneration of retinal photoreceptors leading to progressive visual decline. It is the most common type of inherited retinal dystrophy and has a high burden on both patients and society. This cond...
Saved in:
Main Authors: | Kevin Y. Wu (Author), Merve Kulbay (Author), Dana Toameh (Author), An Qi Xu (Author), Ananda Kalevar (Author), Simon D. Tran (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroinflammation as a Therapeutic Target in Retinitis Pigmentosa and Quercetin as Its Potential Modulator
by: Joseph Thomas Ortega, et al.
Published: (2021) -
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa
by: Chiara Bianca Maria Platania, et al.
Published: (2019) -
Cell Therapy for Retinal Degenerative Diseases: Progress and Prospects
by: Kevin Y. Wu, et al.
Published: (2024) -
Cell technologies in retinitis pigmentosa treatment
by: Zeinet Akhmedyanova, et al.
Published: (2022) -
Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa
by: Miguel Marchena, et al.
Published: (2017)